PMID
Data
Article Title
Organization
Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.

University of California San Diego
Spirotetronate polyketides as leads in drug discovery.

University of California San Diego
Investigating the selectivity of metalloenzyme inhibitors.

University of California San Diego
Novel selective inhibitors of aminopeptidases that generate antigenic peptides.

University of California San Diego
Molecular mechanisms of acquired proteasome inhibitor resistance.

University of California San Diego
Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.

University of California San Diego
Synthesis and biological activity of a novel methylamine-bridged enkephalin analogue (MABE): a new route to cyclic peptides and peptidomimetics.

University of California San Diego
Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.

University of California San Diego
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.

University of California San Diego
Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.

University of California San Diego
Cryptosphaerolide, a cytotoxic Mcl-1 inhibitor from a marine-derived ascomycete related to the genus Cryptosphaeria.

University of California San Diego
Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.

University of California San Diego
Intramolecular Interactions Enhance the Potency of Gallinamide A Analogues against

University of California San Diego
Rational Design and Optimization of m

University of California San Diego
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.

University of California San Diego
Targeted Covalent Inhibition of Small CTD Phosphatase 1 to Promote the Degradation of the REST Transcription Factor in Human Cells.

University of California San Diego
Fragment-Based Identification of Influenza Endonuclease Inhibitors.

University of California San Diego
High affinity CXCR4 inhibitors generated by linking low affinity peptides.

University of California San Diego
Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.

University of California San Diego
A refined model for the somatostatin pharmacophore: conformational analysis of lanthionine-sandostatin analogs.

University of California San Diego
Neolymphostin A Is a Covalent Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitor That Employs an Unusual Electrophilic Vinylogous Ester.

University of California San Diego
Discovery of an Inhibitor of the Proteasome Subunit Rpn11.

University of California San Diego
Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists.

University of California San Diego
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

University of California San Diego
Inhibitors of AKT activity

Merck Sharp & Dohme
CHK1 in CSAR_FULL_RELEASE_3JULY2012

Csar
CDK2-CyclinA in CSAR_FULL_RELEASE_3JULY2012

Csar
CDK2 in CSAR_FULL_RELEASE_3JULY2012

Csar
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.

Cnrs
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.

Mcgill University
Structure-activity relationship studies of 5-benzylaminoimidazo[1,2-c]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors.

Kissei Pharmaceutical
Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa.

Aventis Pharma Deutschland